EMERGENT-5: Cobenfy and Treatment Durability

0:00-12:55

In this episode, we sit down with Dr. Oliver Freudenreich to unpack EMERGENT-5, the year-long trial tracking Cobenfy's real-world durability and safety in schizophrenia. We explore whether early symptom gains hold up over time, what side effects persist, and why blood pressure monitoring now deserves a permanent spot on your checklist. Faculty: Oliver Freudenreich, M.D., F.A.C.L.P. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CME: Quick Take Vol. 85 Xanomeline-Trospium Long-Term: Does Efficacy and Safety Hold Up After One Year?

Publisher

Psychopharmacology and Psychiatry Updates

Link

psychopharmacology.libsyn.com/emergent-5-cobenfy-and-treatment-durability

Published

September 18, 2026

Duration

13 min

Format

Podcast

Category

Lifestyle · Medicine

Source

RSS feed

Host

Psychopharmacology Institute

PA

Psychopharmacology and Psychiatry Updates

@psychopharmacologyandpsychia

#emergent #cobenfy #treatmentdurability #medicine

The Nile